{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:47:02Z","timestamp":1751953622458,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"The Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["A grant-in-aid for Scientific Research (B) KAKENHI Grant Numbers 20H0351700"],"award-info":[{"award-number":["A grant-in-aid for Scientific Research (B) KAKENHI Grant Numbers 20H0351700"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Friends of Leukemia Research Fund, Japan","award":["The Takashi Ogimura Special Award"],"award-info":[{"award-number":["The Takashi Ogimura Special Award"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12185-021-03112-y","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T14:03:27Z","timestamp":1614953007000},"page":"648-655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["New routes to eradicating chronic myelogenous leukemia stem cells by targeting metabolism"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-6004","authenticated-orcid":false,"given":"Kazuhito","family":"Naka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"issue":"12","key":"3112_CR1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake TL, Vetrie D. The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood. 2017;129(12):1595\u2013606.","journal-title":"Blood"},{"issue":"7","key":"3112_CR2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41375-019-0490-0","volume":"33","author":"M Houshmand","year":"2019","unstructured":"Houshmand M, Simonetti G, Circosta P, et al. Chronic myeloid leukemia stem cells. Leukemia. 2019;33(7):1543\u201356.","journal-title":"Leukemia"},{"issue":"8","key":"3112_CR3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","volume":"12","author":"T O'Hare","year":"2012","unstructured":"O\u2019Hare T, Zabriskie MS, Eiring AM, Deininger MW. Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat Rev Cancer. 2012;12(8):513\u201326.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3112_CR4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2016.115","volume":"30","author":"S Sau\u00dfele","year":"2016","unstructured":"Sau\u00dfele S, Richter J, Hochhaus A, Mahon FX. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016;30(8):1638\u201347.","journal-title":"Leukemia"},{"issue":"4","key":"3112_CR5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","volume":"37","author":"TP Braun","year":"2020","unstructured":"Braun TP, Eide CA, Druker BJ. Response and resistance to BCR-ABL1-targeted therapies. Cancer Cell. 2020;37(4):530\u201342.","journal-title":"Cancer Cell"},{"issue":"1","key":"3112_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest. 2011;121(1):396\u2013409.","journal-title":"J Clin Invest"},{"issue":"7198","key":"3112_CR7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","volume":"453","author":"K Ito","year":"2008","unstructured":"Ito K, Bernardi R, Morotti A, et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature. 2008;453(7198):1072\u20138.","journal-title":"Nature"},{"issue":"4","key":"3112_CR8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","volume":"10","author":"FH Heidel","year":"2012","unstructured":"Heidel FH, Bullinger L, Feng Z, et al. Genetic and pharmacologic inhibition of \u03b2-catenin targets imatinib-resistant leukemia stem cells in CML. Cell Stem Cell. 2012;10(4):412\u201324.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3112_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks C, Beigi R, Guo GR, et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008;14(3):238\u201349.","journal-title":"Cancer Cell"},{"issue":"7239","key":"3112_CR10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao C, Chen A, Jamieson CH, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009;458(7239):776\u20139.","journal-title":"Nature"},{"issue":"7281","key":"3112_CR11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Muraguchi T, et al. TGF-\u03b2-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010;463(7281):676\u201380.","journal-title":"Nature"},{"key":"3112_CR12","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/stem.1748","volume":"32","author":"F Pellicano","year":"2014","unstructured":"Pellicano F, Scott MT, Helgason GV, et al. The anti-proliferative activity of kinase inhibitors in chronic myeloid leukaemia cells is mediated by FOXO transcription factors. Stem Cells. 2014;32:2324\u201337.","journal-title":"Stem Cells"},{"issue":"5","key":"3112_CR13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","volume":"20","author":"D Reynaud","year":"2011","unstructured":"Reynaud D, Pietras E, Barry-Holson K, et al. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell. 2011;20(5):661\u201373.","journal-title":"Cancer Cell"},{"issue":"7","key":"3112_CR14","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1172\/JCI127080","volume":"129","author":"A Abraham","year":"2019","unstructured":"Abraham A, Qiu S, Chacko BK, et al. SIRT1 regulates metabolism and leukemogenic potential in CML stem cells. J Clin Invest. 2019;129(7):2685\u2013701.","journal-title":"J Clin Invest"},{"issue":"3","key":"3112_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2013.01.026","volume":"23","author":"S Takeishi","year":"2013","unstructured":"Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A, Nakayama KI. Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell. 2013;23(3):347\u201361.","journal-title":"Cancer Cell"},{"issue":"12","key":"3112_CR16","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1084\/jem.20130112","volume":"210","author":"T Baba","year":"2013","unstructured":"Baba T, Naka K, Morishita S, Komatsu N, Hirao A, Mukaida N. MIP-1\u03b1\/CCL3-mediated maintenance of leukemia-initiating cells in the initiation process of chronic myeloid leukemia. J Exp Med. 2013;210(12):2661\u201373.","journal-title":"J Exp Med"},{"issue":"5","key":"3112_CR17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.stem.2019.02.018","volume":"24","author":"P Agarwal","year":"2019","unstructured":"Agarwal P, Isringhausen S, Li H, et al. Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells. Cell Stem Cell. 2019;24(5):769-84e6.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3112_CR18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","volume":"7","author":"T Simsek","year":"2010","unstructured":"Simsek T, Kocabas F, Zheng J, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010;7(3):380\u201390.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3112_CR19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","volume":"7","author":"K Takubo","year":"2010","unstructured":"Takubo K, Goda N, Yamada W, et al. Regulation of the HIF-1\u03b1 level is essential for hematopoietic stem cells. Cell Stem Cell. 2010;7(3):391\u2013402.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3112_CR20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.stem.2012.10.011","volume":"12","author":"K Takubo","year":"2013","unstructured":"Takubo K, Nagamatsu G, Kobayashi CI, et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell. 2013;12(1):49\u201361.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"3112_CR21","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","volume":"119","author":"H Zhang","year":"2012","unstructured":"Zhang H, Li H, Xi HS, Li S. HIF1\u03b1 is required for survival maintenance of chronic myeloid leukemia stem cells. Blood. 2012;119(11):2595\u2013607.","journal-title":"Blood"},{"issue":"6","key":"3112_CR22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","volume":"158","author":"YH Wang","year":"2014","unstructured":"Wang YH, Israelsen WJ, Lee D, et al. Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell. 2014;158(6):1309\u201323.","journal-title":"Cell"},{"issue":"10","key":"3112_CR23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, Baquero P, Michie AM, et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med. 2017;23(10):1234\u201340.","journal-title":"Nat Med"},{"issue":"3","key":"3112_CR24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","volume":"25","author":"HC Chang","year":"2014","unstructured":"Chang HC, Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab. 2014;25(3):138\u201345.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"3112_CR25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.stem.2020.04.005","volume":"27","author":"K Rothe","year":"2020","unstructured":"Rothe K, Babaian A, Nakamichi N, et al. Integrin-linked kinase mediates therapeutic resistance of quiescent CML stem cells to tyrosine kinase inhibitors. Cell Stem Cell. 2020;27(1):110-24e9.","journal-title":"Cell Stem Cell"},{"key":"3112_CR26","doi-asserted-by":"publisher","first-page":"8039","DOI":"10.1038\/ncomms9039","volume":"6","author":"K Naka","year":"2015","unstructured":"Naka K, Jomen Y, Ishihara K, et al. Dipeptide species regulate p38MAPK-Smad3 signalling to maintain chronic myelogenous leukaemia stem cells. Nat Commun. 2015;6:8039. https:\/\/doi.org\/10.1038\/ncomms9039.","journal-title":"Nat Commun"},{"issue":"6316","key":"3112_CR27","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aag3145","volume":"354","author":"Y Taya","year":"2016","unstructured":"Taya Y, Ota Y, Wilkinson AC, et al. Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantation. Science. 2016;354(6316):1152\u20135.","journal-title":"Science"},{"issue":"7655","key":"3112_CR28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature22314","volume":"545","author":"A Hattori","year":"2017","unstructured":"Hattori A, Tsunoda M, Konuma T, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545(7655):500\u20134.","journal-title":"Nature"},{"issue":"7307","key":"3112_CR29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nature09171","volume":"466","author":"T Ito","year":"2010","unstructured":"Ito T, Kwon HY, Zimdahl B, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 2010;466(7307):765\u20138.","journal-title":"Nature"},{"issue":"8","key":"3112_CR30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nm.2187","volume":"16","author":"MG Kharas","year":"2010","unstructured":"Kharas MG, Lengner CJ, Al-Shahrour F, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med. 2010;16(8):903\u20138.","journal-title":"Nat Med"},{"issue":"2","key":"3112_CR31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9(2):112\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7503","key":"3112_CR32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92\u2013101.","journal-title":"Nature"},{"issue":"11","key":"3112_CR33","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732\u201349.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3112_CR34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Zhang H, Peng C, Li S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet. 2009;41(7):783\u201392.","journal-title":"Nat Genet"},{"issue":"9","key":"3112_CR35","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1172\/JCI66129","volume":"124","author":"Y Chen","year":"2014","unstructured":"Chen Y, Peng C, Abraham SA, et al. Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival. J Clin Invest. 2014;124(9):3847\u201362.","journal-title":"J Clin Invest"},{"issue":"7569","key":"3112_CR36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature15248","volume":"525","author":"S Prost","year":"2015","unstructured":"Prost S, Relouzat F, Spentchian M, et al. Erosion of the chronic myeloid leukaemia stem cell pool by PPAR\u03b3 agonists. Nature. 2015;525(7569):380\u20133.","journal-title":"Nature"},{"issue":"21","key":"3112_CR37","doi-asserted-by":"crossref","first-page":"11148","DOI":"10.1074\/jbc.M116.717801","volume":"291","author":"S Yu","year":"2016","unstructured":"Yu S, Li F, Xing S, Zhao T, Peng W, Xue HH. Hematopoietic and leukemic stem cells have distinct dependence on Tcf1 and Lef1 transcription factors. J Biol Chem. 2016;291(21):11148\u201360.","journal-title":"J Biol Chem"},{"issue":"3","key":"3112_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.stem.2017.08.001","volume":"21","author":"F Li","year":"2017","unstructured":"Li F, He B, Ma X, et al. Prostaglandin E1 and its analog Misoprostol inhibit human CML stem cell self-renewal via EP4 receptor activation and repression of AP-1. Cell Stem Cell. 2017;21(3):359\u201373.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3112_CR39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9258(19)50785-2","volume":"222","author":"EP Kennedy","year":"1956","unstructured":"Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem. 1956;222(1):193\u2013214.","journal-title":"J Biol Chem"},{"issue":"2","key":"3112_CR40","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0021-9258(18)70453-5","volume":"231","author":"WE Lands","year":"1958","unstructured":"Lands WE. Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. J Biol Chem. 1958;231(2):883\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"3112_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R800046200","volume":"284","author":"H Shindou","year":"2009","unstructured":"Shindou H, Shimizu T. Acyl-CoA:lysophospholipid acyltransferases. J Biol Chem. 2009;284(1):1\u20135.","journal-title":"J Biol Chem"},{"issue":"42","key":"3112_CR42","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","volume":"277","author":"A Tokumura","year":"2002","unstructured":"Tokumura A, Majima E, Kariya Y, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 2002;277(42):39436\u201342.","journal-title":"J Biol Chem"},{"issue":"7","key":"3112_CR43","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1074\/jbc.M114.614537","volume":"290","author":"N Ohshima","year":"2015","unstructured":"Ohshima N, Kudo T, Yamashita Y, et al. New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity. J Biol Chem. 2015;290(7):4260\u201371.","journal-title":"J Biol Chem"},{"issue":"12 Pt A","key":"3112_CR44","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bbalip.2016.09.008","volume":"1861","author":"IA Rahman","year":"2016","unstructured":"Rahman IA, Tsuboi K, Hussain Z, et al. Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7. Biochim Biophys Acta. 2016;1861(12 Pt A):1881\u201392.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3112_CR45","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41467-020-18491-9","volume":"11","author":"K Naka","year":"2020","unstructured":"Naka K, Ochiai R, Matsubara E, et al. The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells. Nat Commun. 2020;11(1):4681.","journal-title":"Nat Commun"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-021-03112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-021-03112-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-021-03112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T10:12:32Z","timestamp":1620209552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-021-03112-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3112"],"URL":"https:\/\/doi.org\/10.1007\/s12185-021-03112-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The author was supported by a grant-in-aid from Carna Biosciences Inc., Japan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}